UNITED STATES ~~SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of theSecurities Exchange Act of 1934~~

~~Date~~ SECURITIES ofAND ~~Report:~~EXCHANGE ~~November 09, 2010~~COMMISSION ~~(Date of earliest event reported)~~ NMT Medical, Inc. (Exact name of registrant as specified in its charter) DE (State or other jurisdiction of incorporation) 000-21001 (Commission File Number) 95-4090463 (IRS Employer Identification Number) 27 Wormwood Street, Boston, MA (Address of principal executive offices) 02210-1625 (Zip Code) 617-737-0930(Registrant's telephone number, including area code) Not Applicable(Former Name or Former Address, if changed since last report)

~~Item 2.02. Results of Operations and Financial Condition On November 9~~ Washington, ~~2010, NMT Medical, Inc~~D. ~~announced its financial results for the quarter ended September 30, 2010~~C. The full text of the press release issued in connection with the announcement is attached as Exhibit 99.1 to this Current Report on Form 8-K. The information in this Current Report on Form 8-K and the Exhibit attached hereto shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing. Item 9.01. Financial Statements and Exhibits (a) Financial statements: None (b) Pro forma financial information: None (c) Shell company transactions: None (d) Exhibits 99.1 Press Release of NMT Medical, Inc. dated November 09, 2010 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.20549

~~Dated:~~ Form ~~November~~8-K ~~09, 2010 NMT MEDICAL, INC. By: /s/ Richard E. Davis Richard E. Davis President and Chief Executive Officer~~

Exhibit Index
Exhibit No.	Description
99.1	Press Release of NMT Medical, Inc. dated November 09, 2010

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): 01/04/2011

NMT Medical, Inc.

(Exact name of registrant as specified in its charter)

Commission File Number: 000-21001

Delaware		95-4090463
(State or other jurisdiction of		(IRS Employer
incorporation)		Identification No.)

27 Wormwood Street, Boston, MA 02210-1625

(Address of principal executive offices, including zip code)

617-737-0930

(Registrant’s telephone number, including area code)

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

[  ]   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

[  ]   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

[  ]   Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

[  ]   Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 1.01. Entry into a Material Definitive Agreement

On January 4, 2011, NMT Medical, Inc. (the "Registrant") entered into a Factoring and Security Agreement (the "Agreement") with LSQ Funding Group, L.C. ("LSQ").

The agreement provides for borrowings up to $2 million for working capital and other general corporate purposes. The credit facility has a one-year term and is subject to a borrowing base calculated as a percentage of domestic receivables that are pledged as collateral against the loan.

The Agreement provides for certain events of default by the Registrant, including payment default, and other customary events of default.

The obligations of the Registrant are secured by the Registrant's domestic accounts receivable.

Item 1.02. Termination of a Material Definitive Agreement

The Registrant also recently terminated a Loan and Security Agreement that it entered into with Silicon Valley Bank on June 26, 2009. The Registrant incurred a de minimis amount of termination costs in connection with the termination of the Loan and Security Agreement. The Registrant did not borrow against the Loan and Security Agreement at any time during the term of the agreement.

Item 9.01. Financial Statements and Exhibits

(a) Financial statements:

None

(b) Pro forma financial information:

None

(d) Exhibits

99.1 Press Release of NMT Medical, Inc. dated January 04, 2011

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

		Richard E. Davis


Date: January 07, 2011	By:	/s/ Richard E. Davis
		Richard E. Davis
		President and Chief Executive Officer

EXHIBIT INDEX

Exhibit No.		Description
EX-99.1		Press release of NMT Medical, Inc. dated January 4, 2011

Filing Compare · NMT MEDICAL INC